Adiponectin measures indicate pain severity, study suggests

03/21/2013 | MedPage Today (free registration)

A small study that included 20 women with migraines found that adiponectin measures could predict pain severity and treatment response, Johns Hopkins University researchers reported in the journal Headache. Ratios of high-to-low molecular weight adiponectin could be tied to severity of pain, indicating the potential for use as a migraine biomarker and drug target.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR